Sarepta Therapeutics Inc.

About Sarepta Therapeutics Inc.

Sarepta Therapeutics is a global biotechnology company focused on engineering precision genetic medicine to address rare diseases. Their mission is to transform genetic understanding into effective treatments, shorten drug development timelines, and build significant gene therapy manufacturing capacity while rethinking access and reimbursement models for innovative treatments.

Products & Services

FDA-Approved Treatments:Sarepta offers FDA-approved treatments for rare diseases, with further details available on their product page.

Gene Therapy, RNA Technologies, and Gene Editing Platforms:Sarepta develops solutions using advanced platforms including gene therapy, RNA technologies, and gene editing, aimed at treating rare diseases.

Pipeline and Clinical Trials:Sarepta has a pipeline of potential treatments and ongoing clinical trials focused on rare diseases.

RNA-based therapeutics

Gene therapies

Specialties

Precision Genetic Medicine Gene Therapy RNA Technologies Gene Editing Rare Disease Treatment Manufacturing of Gene Therapies Duchenne muscular dystrophy Limb-girdle muscular dystrophy Facioscapulohumeral muscular dystrophy Myotonic dystrophy type 1 siRNA Gene therapy Manufacturing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Convertible Senior Notes Exchange T: - FT: Convertible Senior Notes Exchange	A: 291400000 MR: - FA: approximately $291.4 million FAN: 291400000	D: 2025-12-11 FD: 2025-12-11	-
2	RT: Debt T: - FT: Debt	A: 600000000 MR: - FA: $600 million FAN: 600000000	D: 2025-02-14 FD: 2025-02-14	9 investors

Convertible Senior Notes Exchange Latest

2025-12-11

$291.4M

Debt 2025-02-14

$600.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Douglas S. Ingram

Chief Executive Officer

I

Ian M. Estepan

President and Chief Operating Officer

L

Louise R. Rodino-Klapac

President, R&D and Technical Operations

D

Diane Berry

Executive Vice President, Chief Global Policy & Advocacy Officer

P

Patrick E. Moss

Executive Vice President, Chief Commercial Officer

A

Alison Nasisi

Executive Vice President, Chief People Officer

View 20 more team members with Pro

Unlock Full Team Directory

Recent News